|
Benign prostatic hyperplasia (BPH) |
|
Biochemical progression |
|
Biopsy core |
|
Clinical progression |
|
Clinical stage |
|
Digital rectal examination (DRE) |
|
Distant progression |
|
Extracapsular extension |
|
Gene-based |
|
Gleason score |
|
Hormone-refractory prostate cancer |
|
Indolent cancer |
|
Local progression |
|
Neo-adjuvant |
|
Over-staged cancer |
|
Over-treatment |
|
Pathological stage |
|
Post-operative staging |
|
Pre-operative staging |
|
Progression |
|
Progression-free |
|
Progression-free survival |
|
Prostate biopsy |
|
Prostate CAncer gene 3 (PCA3) |
|
Prostate specific antigen (PSA) |
|
Prostatitis |
|
Radical prostatectomy |
|
Seminal vesicle |
|
Spread |
|
Stage |
|
Surgical margin |
|
T1 |
|
T2 |
|
T3 |
|
T4 |
|
TNM (tumour, nodes, metastases) classification system |
|
Tumour confined to the prostate |
|
Tumour spreads beyond the prostate |
|
Tumour spreads even further |
|
Watchful waiting |
